PARNAX LAB LTD. - 506128 - Shareholding for the Period Ended June 30, 2019
Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here15-07-2019
15-07-2019
PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bhoomi ThakkarDesignation :- Company Secretary and Compliance Officer12-07-2019
Parnax Lab Ltd - 506128 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bhoomi ThakkarDesignation :- Company Secretary and Compliance Officer12-07-2019
PARNAX LAB LTD. - 506128 - Closure of Trading Window
Pursuant to SEBI(Prohibition of Insider Trading) Regulations, 2015 as amended and as per Company's Code of Conduct for prevention of Insider Trading, read with BSE Circular No. LIST/COMP/01/2019-20 dated April 2, 2019, the Trading Window for dealing in securities of the Company is closed for all Directors, Designated Employees and other persons covered under the Code from end of June Quarter 2019 till the expiry of 48 hours after the declaration of the Financial Results for the quarter ended June 30, 2019.01-07-2019
PARNAX LAB LTD. - 506128 - Results- Audited Financial Results For The Quarter And Year Ended March 31, 2019
Kindly find enclosed herewith the following: 1. A Copy of Standalone and Consolidated Audited Financial results for the quarter and year ended 31st March, 2019 along with Auditor Report thereon; 2. Declaration pursuant to Regulation 33(3)(d) as amended by the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 201530-05-2019
PARNAX LAB LTD. - 506128 - Outcome of Board Meeting
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Thursday, 30th May, 2019 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Audited Standalone and Consolidated Financial Results along with Auditor Report for the quarter and year ended 31st March, 2019 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Approved Half Yearly Standalone Statement of Assets and Liabilities for year ended 31st March, 2019. 3. Re-appointment of Mr. Baiju M. Shah as Managing Director of the Company. The Meeting commenced at 5.00 p.m. and concluded at 6.00 p.m.30-05-2019
PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Audited Stand-Alone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2019.
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve 1. To approve Standalone and Consolidated Audited IND-AS compliant Financial Results along with Auditor Report for the quarter and year ended on 31st March, 2019 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. To approve the statement of assets and liabilities for the half year ended March 31, 2019. 3. Re-appointment of Mr. Baiju Shah (DIN: 00440806) as Managing Director of the Company. 4. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.18-05-2019
PARNAX LAB LTD. - 506128 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayPARNAX LAB LTD. 2CININE383L01019 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 9.9606108 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Bhoomi Thakkar Designation: Company Secretary & Compliance Officer EmailId: compliance@naxparlab.com Name of the Chief Financial Officer: Baiju Shah Designation: Chief Financial Officer EmailId: baijushah@naxparlab.com Date: 30/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.30-04-2019
Parnax Lab Ltd - 506128 - Certificate Under Regulation 40(9) Of Securities Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015
Please find enclosed herewith the Compliance Certificate pursuant to regulation 40(9) of SEBI (LODR) Regulation,2015 for the half year ended 31st March, 2019.17-04-2019